shutterstock_1425318470_photobyphm
Photobyphm / Shutterstock.com
29 August 2019AmericasRory O'Neill

US court backs Sanofi and Regeneron in Amgen suit

A US judge yesterday, August 28 ruled in favour of Sanofi and Regeneron in the pharmaceutical companies’ long-running patent dispute with Amgen over the cholesterol drug Praluent.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
Big Pharma
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.

More on this story

Big Pharma
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
Big Pharma
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.

More on this story

Big Pharma
5 June 2019   A German court has rejected a bid from French pharmaceutical company Sanofi to have a patent infringement case dismissed.
Big Pharma
24 August 2021   Regeneron wants a Manhattan district court to toss a lawsuit that claims it infringed on patents in the development and testing of COVID-19 treatments.